J 2017

The burden and epidemiology of community-acquired central nervous system infections: a multinational study

ERDEM, Hakan; A. INAN; E. GUVEN; S. HARGREAVES; L. LARSEN et. al.

Základní údaje

Originální název

The burden and epidemiology of community-acquired central nervous system infections: a multinational study

Autoři

ERDEM, Hakan; A. INAN; E. GUVEN; S. HARGREAVES; L. LARSEN; G. SHEHATA; Eva PERNICOVÁ; E. KHAN; Lenka BAŠTÁKOVÁ; S. NAMANI; A. HARXHI; T. ROGANOVIC; B. LAKATOS; S. UYSAL; O. R. SIPAHI; A. CRISAN; E. MIFTODE; Roman STEBEL ORCID; B. JEGOROVIC; Z. FEHER; C. JEKKEL; N. PANDAK; A. MORAVVEJI; H. YILMAZ; A. KHALIFA; U. MUSABAK; S. YILMAZ; A. JOUHAR; N. OZTOPRAK; X. ARGEMI; M. BALDEYROU; G. BELLAUD; R. V. MOROTI; R. HASBUN; L. SALAZAR; R. TEKIN; A. CANESTRI; L. CALKIC; L. PRATICO; F. YILMAZ-KARADAG; L. SANTOS; A. PINTO; F. KAPTAN; P. BOSSI; J. ARON; A. DUISSENOVA; G. SHOPAYEVA; B. UTAGANOV; S. GRGIC; G. ERSOZ; A. K. L. WU; K. C. LUNG; A. BRUZSA; L. B. RADIC; H. KAHRAMAN; M. MOMEN-HERAVI; S. KULZHANOVA; F. RIGO; M. KONKAYEVA; Z. SMAGULOVA; T. TANG; P. CHAN; S. AHMETAGIC; H. POROBIC-JAHIC; F. MORADI; S. KAYA; Y. CAG; A. BOHR; C. ARTUK; I. CELIK; M. AMSILLI; H. C. GUL; A. CASCIO; M. LANZAFAME a M. NASSAR

Vydání

European Journal of Clinical Microbiology & Infectious Diseases, New York, Springer, 2017, 0934-9723

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30303 Infectious Diseases

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.537

Kód RIV

RIV/00216224:14110/17:00098556

Organizační jednotka

Lékařská fakulta

UT WoS

000407582200010

EID Scopus

2-s2.0-85017266797

Klíčová slova anglicky

Central nervous system infections; Epidemiology; Streptococcus pneumoniae; Neurosyphilis; Neuroborreliosis; CNS tuberculosis

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 21. 3. 2018 18:00, Soňa Böhmová

Anotace

V originále

Risk assessment of central nervous system (CNS) infection patients is of key importance in predicting likely pathogens. However, data are lacking on the epidemiology globally. We performed a multicenter study to understand the burden of community-acquired CNS (CA-CNS) infections between 2012 and 2014. A total of 2583 patients with CA-CNS infections were included from 37 referral centers in 20 countries. Of these, 477 (18.5%) patients survived with sequelae and 227 (8.8%) died, and 1879 (72.7%) patients were discharged with complete cure. The most frequent infecting pathogens in this study were Streptococcus pneumoniae (n = 206, 8%) and Mycobacterium tuberculosis (n = 152, 5.9%). Varicella zoster virus and Listeria were other common pathogens in the elderly. Although staphylococci and Listeria resulted in frequent infections in immunocompromised patients, cryptococci were leading pathogens in human immunodeficiency virus (HIV)-positive individuals. Among the patients with any proven etiology, 96 (8.9%) patients presented with clinical features of a chronic CNS disease. Neurosyphilis, neurobrucellosis, neuroborreliosis, and CNS tuberculosis had a predilection to present chronic courses. Listeria monocytogenes, Staphylococcus aureus, M. tuberculosis, and S. pneumoniae were the most fatal forms, while sequelae were significantly higher for herpes simplex virus type 1 (p < 0.05 for all). Tackling the high burden of CNS infections globally can only be achieved with effective pneumococcal immunization and strategies to eliminate tuberculosis, and more must be done to improve diagnostic capacity.